Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 29, 2021

Study Completion Date

March 29, 2021

Conditions
Ventricular Tachycardia (VT)
Interventions
DEVICE

Implantable Cardioverter Defibrillator (ICD)

An ICD is a battery-powered device placed under the skin that keeps track of heart rate. Thin wires connect the ICD to the heart. If an abnormal heart rhythm is detected, the device will deliver an electric shock to restore a normal heartbeat.

PROCEDURE

Catheter Ablation

Catheter ablation is a procedure that uses radiofrequency energy to destroy a small area of heart tissue that is causing rapid and irregular heartbeats. Destroying this tissue helps restore the heart's regular rhythm.

Trial Locations (12)

85006

Banner University Medical Center Phoenix, Phoenix

Unknown

Fuwai Cardiovascular Hospital, Beijing

Huaxi Hospital, Chengdu

Guangdong General Hospital, Guangzhou

Sir Run Run Shaw Hospital, Hangzhou

Nanjing First Affiliated Hospital, Nanjing

PLA Shenyang General Hospital, Shenyang

Dokkyo Medical University, Saitama Medical Center, Saitama

Kyorin University Hospital, Tokyo

Tsukuba University, Tsukuba

Korea University, Seoul

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

University of Arizona

OTHER

NCT02848781 - Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial | Biotech Hunter | Biotech Hunter